S
Scott J Robbie
Researcher at UCL Institute of Ophthalmology
Publications - 37
Citations - 3460
Scott J Robbie is an academic researcher from UCL Institute of Ophthalmology. The author has contributed to research in topics: Macular degeneration & Choroidal neovascularization. The author has an hindex of 16, co-authored 35 publications receiving 3146 citations. Previous affiliations of Scott J Robbie include University of Murcia & University College London.
Papers
More filters
Journal ArticleDOI
Dupilumab-Induced, Tralokinumab-Induced, and Belantamab Mafodotin–Induced Adverse Ocular Events—Incidence, Etiology, and Management
TL;DR: In this article, the authors present the current knowledge concerning adverse ocular events associated with three monoclonal antibody therapies: dupilumab, tralokinumab and belantamab mafodotin.
Journal Article
Absence Of Ocular Malignant Transformation After Subretinal Delivery Of Raav2/2 Or Hiv-1 Vectors In P53 Knockout Mice
Kamaljit S. Balaggan,Yanai Duran,Prateek K. Buch,A MacNeil,Scott J Robbie,S. E. Barker,Anastasios Georgiadis,James W B Bainbridge,Alex K. Smith,Robin R. Ali +9 more
Journal Article
Visually-Guided Mobility in Patients Treated With Gene Therapy for Leber's Congenital Amaurosis
Gary S. Rubin,James W B Bainbridge,H. Roche,Scott J Robbie,Anthony T. Moore,Taku Fujiyama,Nick Tyler,Robin R. Ali +7 more
Journal ArticleDOI
Authors’ response to Konstantopoulos et al
TL;DR: It should be noted, however, that the study did not actually conclude that older age was not associated with an increased risk of adverse events, and the results cannot be attributed to any single cause.
Journal ArticleDOI
Viral infections need to be excluded from the cohort for the results to be truly meaningful.
TL;DR: This study reached a similar conclusion to the study abstracted in EBM, which is not clear in the method by which a diagnosis of conjunctivitis is made, how viral and bacterial cases are differentiated.